Rossella Menghini Selected Research

Rossella Menghini Research Topics

Disease

15	Inflammation (Inflammations) 04/2023 - 04/2005
13	Atherosclerosis 01/2020 - 10/2009
10	Insulin Resistance 01/2022 - 02/2006
7	Obesity 01/2022 - 10/2007
6	Type 2 Diabetes Mellitus (MODY) 04/2023 - 10/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2004
5	Hyperglycemia 05/2021 - 07/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 12/2021 - 12/2013
3	Dysbiosis 04/2023 - 01/2016
3	Glucose Intolerance 12/2022 - 12/2005
3	Fatty Liver 01/2022 - 01/2016
3	Atherosclerotic Plaque (Atheroma) 12/2013 - 10/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2007
2	Hypertension (High Blood Pressure) 11/2021 - 10/2015
2	Fibrosis (Cirrhosis) 05/2021 - 01/2021
2	Neoplasms (Cancer) 12/2019 - 01/2017
2	Myocardial Infarction 10/2015 - 04/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 02/2009 - 01/2004
1	Hypercholesterolemia 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	COVID-19 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Weight Gain 12/2021
1	Carotid Artery Diseases 11/2021
1	Diabetes Mellitus 11/2021
1	Renal Insufficiency (Renal Failure) 11/2021
1	Proteinuria 05/2021
1	Hypertrophy 01/2021
1	Albuminuria 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2018
1	Overweight 03/2017

Drug/Important Bio-Agent (IBA)

10	Insulin (Novolin)FDA Link 02/2018 - 07/2002
9	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 07/2003
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
8	Tissue Inhibitor of Metalloproteinase-3IBA 01/2017 - 12/2005
4	LipidsIBA 12/2022 - 02/2012
4	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 05/2021 - 12/2013
4	Peptide Hydrolases (Proteases)FDA Link 12/2019 - 02/2012
4	DisintegrinsIBA 01/2017 - 10/2009
4	Insulin ReceptorIBA 12/2011 - 07/2003
4	ADAM17 ProteinIBA 01/2010 - 12/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 09/2015
3	CollagenIBA 05/2021 - 01/2012
3	Tissue Inhibitor of MetalloproteinasesIBA 12/2019 - 02/2012
3	Metalloproteases (Metalloproteinases)IBA 01/2017 - 10/2009
3	Matrix Metalloproteinases (MMPs)IBA 10/2009 - 12/2005
2	Transcription Factors (Transcription Factor)IBA 12/2022 - 12/2007
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 02/2014
2	InterleukinsIBA 10/2021 - 06/2014
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 02/2018
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2019 - 01/2017
2	Apolipoproteins E (ApoE)IBA 10/2015 - 08/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007 - 12/2005
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2006 - 07/2002
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023
1	Blood Glucose (Blood Sugar)IBA 11/2023
1	insulin degludecIBA 04/2023
1	Liraglutide FDA Link 04/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	CholesterolIBA 01/2023
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Phospholipases A2 (Phospholipase A2)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	UbiquitinIBA 01/2022
1	TRAM 34IBA 12/2021
1	Untranslated RNA (Noncoding RNA)IBA 12/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2021
1	Long Noncoding RNAIBA 12/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2021
1	oxidized low density lipoproteinIBA 11/2021
1	C-Reactive ProteinIBA 11/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	ResistinIBA 10/2021
1	Ramipril (Altace)FDA LinkGeneric 05/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2021
1	2- ((4- methylphenyl)sulfonyl)- 5- nitrofuranIBA 05/2021
1	VimentinIBA 05/2021
1	Lysine (L-Lysine)FDA Link 05/2021
1	Periodic AcidIBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	nephrinIBA 01/2021
1	NPHS2 proteinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2020

Therapy/Procedure

3	Therapeutics 04/2023 - 11/2021
1	Drug Therapy (Chemotherapy) 11/2023
1	Phototherapy (Light Therapy) 12/2022
1	Injections 01/2021